Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation

Published:2022-04 Issue:4 Volume:28 Page:196-202
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Bognàr Tim^ORCID,Bartelink Imke H.^ORCID,Egberts Toine C.G.,Rademaker Carin M.A.,Versluys A. Birgitta,Slatter Mary A.,Kletzel Morris,Nath Christa E.,Cuvelier Geoffrey D.E^ORCID,Savic Rada M.,Dvorak Christopher^ORCID,Long-Boyle Janel R.,Cowan Morton J.^ORCID,Bittencourt Henrique^ORCID,Bredius Robbert G.M.^ORCID,Güngör Tayfun,Shaw Peter J.^ORCID,Ansari Marc,Hassan Moustapha,Krajinovic Maja,Hempel Georg^ORCID,Marktel Sarah,Chiesa Robert,Théoret Yves,Lund Troy^ORCID,Orchard Paul J.^ORCID,Wynn Robert F.,Boelens Jaap Jan^ORCID,Lalmohamed Arief

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference32 articles.

1. Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis;Bartelink;Lancet Haematol,2016

2. Busulfan systemic exposure and its relationship with efficacy and safety in hematopoietic stem cell transplantation in children: A meta-analysis;Feng;BMC Pediatr,2020

3. Risk factors for development of and progression of hepatic veno-occlusive disease/sinusoidal obstruction syndrome;Corbacioglu;Biol Blood Marrow Transplant,2019

4. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT);Mohty;Bone Marrow Transplant,2015

5. Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted children;Philippe;Bone Marrow Transplant,2019

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT);Bone Marrow Transplantation;2024-09-13

2. Risk Factors for Sinusoidal Obstruction Syndrome After Hematopoietic Stem Cell Transplantation in Children and Young Adults: A Systematic Review and Meta‐Analysis;Clinical Transplantation;2024-09

3. The Role of the Conditioning Regimen for Autologous and Ex Vivo Genetically Modified Hematopoietic Stem Cell-based Therapies: Recommendations from the ISCT Stem Cell Engineering Committee;Cytotherapy;2024-09

4. Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric Protocols;Transplantation and Cellular Therapy;2024-07

5. Busulfan Exposure Target Attainment in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation: A Single Day Versus a Multiple Day Therapeutic Drug Monitoring Regimen;Transplantation and Cellular Therapy;2024-07